This topic contains a solution. Click here to go to the answer

Author Question: Name three important factors that increase the risk of developing coronary heart disease. What ... (Read 189 times)

Beheh

  • Hero Member
  • *****
  • Posts: 520
Name three important factors that increase the risk of developing coronary heart disease.
 
  What will be an ideal response?

Question 2

The activities of the cell are directed by which cell structure?
 
  A. Cytoplasm
  B. Organelles
  C. Cell membranes
  D. Nucleus



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mtmmmmmk

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

elevated blood lipids, high blood pressure, cigarette smoking, diabetes

Answer to Question 2

D




Beheh

  • Member
  • Posts: 520
Reply 2 on: Jun 25, 2018
:D TYSM


anyusername12131

  • Member
  • Posts: 327
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library